To address the cognitive symptoms of schizophrenia, new pharmacological approaches are being developed that target specific aspects of various neurotransmitter systems, including

Question

Quizplus · Accepted Answer

Research has identified dysregulation in multiple neurotransmitter systems in schizophrenia, including acetylcholine, dopamine, and glutamate. New pharmacological approaches are being developed to target specific aspects of these systems in order to address the cognitive symptoms of schizophrenia. While other neurotransmitter systems, such as serotonin and GABA, have also been implicated in the disorder, the most promising interventions currently under investigation focus on acetylcholine, dopamine, and glutamate.

To Address the Cognitive Symptoms of Schizophrenia, New Pharmacological Approaches